Bibliometric analysis of Crohn's disease in children, 2014-2024

Yanjing Zhu1,2, Yunhong Ma3, Zhengjiu Cui4

  • 1The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.

PubMed

Insights

Pediatric Crohn's disease research is increasing, with the United States leading publications. This bibliometric analysis visualizes trends and key contributors in pediatric Crohn's disease literature to aid future diagnosis and treatment.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Diseases
  • Bibliometric Analysis

Background:

  • Crohn's disease incidence is rising in children, impacting their health and families.
  • Extensive research exists, but bibliometric analyses using visualization methods are lacking.
  • This study addresses the need for a statistical overview of pediatric Crohn's disease literature.

Purpose of the Study:

  • To statistically analyze published literature on pediatric Crohn's disease.
  • To identify key authors, countries, institutions, and journals in the field.
  • To provide a visual summary to support future diagnosis and treatment.

Main Methods:

  • Screened literature from Web of Science Core Collection.
  • Utilized Citespace (6.2.R4) and VOSviewer (1.6.18) for visualization and analysis.
  • Analyzed authors, countries, institutions, journals, references, and keywords.

Main Results:

  • Included 3,177 publications, showing an increasing trend.
  • Dan Turner published most (78 articles); A. Levine was most cited author.
  • United States and Tel Aviv University led in publications; Journal of Pediatric Gastroenterology and Nutrition published most.
  • Key documents included ESPGHAN Revised Porto Criteria and ECCO-ESPGHAN Guideline Update.
  • "Inflammatory bowel disease" was the most frequent keyword.

Conclusions:

  • Provides a visual summary of pediatric Crohn's disease research.
  • Highlights key contributors and trends in the field.
  • Aims to foster international collaboration and advance research in pediatric Crohn's disease.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
144
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
123
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
288
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
103